Cinctive Capital Management LP
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1787258
New York, NY
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,268,651
+$11,014,071 QoQ
Shares Held
26,712
+429.1% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#316
of 1,705 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Dec 31, 2023CallValue
$10,172,250
CallShares
25,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cinctive Capital Management LP holds $200,361,017 across 44 Biotechnology names. VRTX ranks #3 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
350,165 | $46,477,400 | |
| 2 | INSM |
INSMED Inc
|
161,996 | $17,272,013 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
26,712 | $13,268,651 | |
| 4 | CYTK |
Cytokinetics Inc
|
137,838 | $11,742,419 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
226,140 | $8,003,094 | |
| 6 | NTHI |
Neonc Technologies Holdings, Inc.
|
1,607,464 | $7,281,811 | |
| 7 | ERAS |
Erasca, Inc.
|
391,642 | $7,174,881 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
16,367 | $6,083,122 |
All Filings in VRTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,268,651 | 26,712 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,254,580 | 5,049 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $6,734,634 | 13,891 | Shares | Sole | 2025-05-15 | |
| 2023-12-31 | $10,172,250 | 25,000 | Call | Sole | 2024-02-14 | |
| 2022-06-30 | $3,205,361 | 11,375 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $1,132,038 | 5,155 | Shares | Sole | 2022-02-14 | |
| 2020-09-30 | $3,392,520 | 12,467 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $6,700,354 | 23,080 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,994,258 | 8,381 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||